av/enochian-biosciences--big.svg

COM:ENOCHIANBIO

Renovaro Biosciences

  • Stock

USD

Last Close

0.70

04/08 19:58

Market Cap

45.38M

Beta: -

Volume Today

87.29K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '22
Jun '23
Jun '24
net income
-113.43M
-
-39.68M
65.02%
-80.65M
103.23%
depreciation and amortization
123.59K
-
113.50K
8.17%
702.46K
518.93%
deferred income tax
stock based compensation
5.49M
-
3.54M
35.62%
4.67M
32.19%
change in working capital
1.42M
-
4.31M
204.23%
4.75M
10.44%
accounts receivables
-1.11M
-
inventory
accounts payables
1.08M
-
3.89M
260.21%
4.06M
4.17%
other working capital
5.86M
-
other non cash items
-2.60M
-
995.80K
138.31%
59.55M
5,879.96%
net cash provided by operating activities
-15.73M
-
-11.77M
25.16%
-10.97M
6.82%
investments in property plant and equipment
-5.16K
-
-29.77K
477.46%
-70.43K
136.55%
acquisitions net
65.85K
-
purchases of investments
sales maturities of investments
other investing activites
-1.26M
-
net cash used for investing activites
-5.16K
-
-29.77K
477.46%
-1.26M
4,132.48%
debt repayment
-560.85K
-
-1.12M
100.01%
-7.18M
539.67%
common stock issued
4.68M
-
4.01M
14.21%
2.00M
50.15%
common stock repurchased
dividends paid
other financing activites
3.34M
-
net cash used provided by financing activities
4.25M
-
4.52M
6.23%
10.52M
132.94%
effect of forex changes on cash
-5.24K
-
-8.39K
60.21%
60.14K
816.39%
net change in cash
-11.49M
-
-7.30M
36.50%
-1.65M
77.34%
cash at beginning of period
20.66M
-
9.17M
55.61%
1.87M
79.56%
cash at end of period
9.17M
-
1.87M
79.56%
220.47K
88.24%
operating cash flow
-15.73M
-
-11.77M
25.16%
-10.97M
6.82%
capital expenditure
-5.16K
-
-29.77K
477.46%
-70.43K
136.55%
free cash flow
-15.74M
-
-11.80M
24.99%
-11.04M
6.46%

All numbers in USD (except ratios and percentages)